Transforming a bad trip often means giving it a place and purpose in one’s larger life story.
Bad trips look much different in psychedelic therapy than in uncontrolled settings.
What's similar and different about the R and S isomers of ketamine?
Seventeen 4-acetoxy and 4-hydroxy substituted derivatives “have psilocybin-like pharmacological properties.”
“We have some [compounds] now that are unlike anything you’ve ever seen before.”
The link between oxytocin and MDMA is less straightforward than once thought.
Receptor testing of the affinity and potency of compounds is a critical component of psychedelic research.
Patent filings indicate that CaaMTech was the first company to propose an entourage effect in psychedelic compounds.
Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.